Novel and Innovative Approaches in the Management of Urological Tumors

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 127

Special Issue Editor


E-Mail Website
Guest Editor
START Lisbon, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal
Interests: prostate cancer; bladder cancer; melanoma; non melanoma skin cancers; cancer clinical trials; immunotherapy; colorectal cancer; bone metastasis

Special Issue Information

Dear Colleagues,

Urological tumors represent a significant challenge in the realm of oncology, necessitating novel and groundbreaking approaches. As a Medical Oncologist who focuses on both urology and oncology, I am pleased to announce that a Special Issue of Life has been commissioned to address the latest developments in these fields.

This Special Issue aims to shed light on innovative methods for diagnosing, treating, and improving outcomes in patients with urological tumors. Topics of interest include but are not limited to the following:

  • Early Detection Techniques: Exploring cutting-edge screening programs for the early identification of urological tumors.
  • Diagnostic Tools: Introducing new diagnostic tools that enhance precision in urological cancer diagnosis.
  • Surgical Innovations: Highlighting advances in surgical approaches and techniques for both early and locally advanced urological tumors.
  • Therapeutic Technologies: Showcasing new therapeutic technologies and strategies for curative interventions in urological malignancies.
  • Targeted Therapies: Discussing systemic targeted therapies tailored to the unique characteristics of urological tumors.
  • Immunotherapies: Examining the application of immunotherapies in the personalized treatment of urological cancers.

We invite submissions of studies that contribute to facilitating a deeper understanding of the evolving landscape in urological oncology. This Special Issue aims to provide valuable insights into diagnostic and therapeutic approaches, offering readers a glimpse into the future of urological cancer management.

Your contributions will play a vital role in advancing our understanding of urological tumors and fostering innovations in their treatment. We look forward to receiving your manuscripts by the submission deadline.

Dr. André Mansinho
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • urological tumors
  • early detection
  • diagnosis
  • novel therapies

Published Papers

This special issue is now open for submission.
Back to TopTop